Skip to main content
Top
Published in: Journal of Natural Medicines 4/2022

25-05-2022 | Alkaloids | Original Paper

Bioactivity inspired C19-diterpenoid alkaloids for overcoming multidrug-resistant cancer

Authors: Koji Wada, Masuo Goto, Emika Ohkoshi, Kuo-Hsiung Lee, Hiroshi Yamashita

Published in: Journal of Natural Medicines | Issue 4/2022

Login to get access

Abstract

The pharmacological activities of C19-diterpenoid alkaloids are related to their basic skeletons (e.g., aconitine-type or lycoctonine-type). Also, few studies have been reported on the chemosensitizing effects of diterpenoid alkaloids. Consequently, this study was aimed at determining the chemosensitizing effects of synthetic derivatives of lycoctonine-type C19-diterpenoid alkaloids on a P-glycoprotein (P-gp)-overexpressing multidrug-resistant (MDR) cancer cell line KB-VIN. The acyl-derivatives of delpheline and delcosine showed moderate cytotoxicity against chemosensitive cancer cell lines. Among non-cytotoxic synthetic analogs (114), several derivatives effectively and significantly sensitized MDR cells by interfering with the drug transport function of P-gp to three anticancer drugs, vincristine, paclitaxel, and doxorubicin. The chemosensitizing effect of derivatives 2, 4, and 6 on KB-VIN cells against vincristine were more potent than 5 μM verapamil, and derivatives 4 and 13 were more effective than 5 μM verapamil for paclitaxel. Among them, 2 in particular increased the sensitivity of KB-VIN cells to vincristine by 253-fold.
Literature
1.
go back to reference Wang FP, Chen QH, Liu XY (2010) Diterpenoid alkaloids. Nat Prod Rep 27:529–570CrossRef Wang FP, Chen QH, Liu XY (2010) Diterpenoid alkaloids. Nat Prod Rep 27:529–570CrossRef
2.
go back to reference Amiya T, Bando H (1988) Aconitum alkaloids. In: Brossi A (ed) The Alkaloids, vol 34. Academic Press, San Diego, pp 95–179 Amiya T, Bando H (1988) Aconitum alkaloids. In: Brossi A (ed) The Alkaloids, vol 34. Academic Press, San Diego, pp 95–179
3.
go back to reference Benn MH, Jacyno JM (1983) The toxicology and pharmacology of diterpenoid alkaloids. In: Pelletier SW (ed) Alkaloids: Chemical and Biological Perspectives, Vol. 1; Wiley-Interscience: New York, pp 153–210 Benn MH, Jacyno JM (1983) The toxicology and pharmacology of diterpenoid alkaloids. In: Pelletier SW (ed) Alkaloids: Chemical and Biological Perspectives, Vol. 1; Wiley-Interscience: New York, pp 153–210
4.
go back to reference Baumann M, Krause M (2004) Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results. Radiother Oncol 72:257–266CrossRef Baumann M, Krause M (2004) Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results. Radiother Oncol 72:257–266CrossRef
5.
go back to reference Diedelot C, Mirjolet JF, Barberi-Heyob M (2002) Radiation could induce p53-independent and cell cycle-unrelated apoptosis in 5-fluorouracil radiosensitized head and neck carcinoma cells. Can J Physiol Pharmacol 80:638–643CrossRef Diedelot C, Mirjolet JF, Barberi-Heyob M (2002) Radiation could induce p53-independent and cell cycle-unrelated apoptosis in 5-fluorouracil radiosensitized head and neck carcinoma cells. Can J Physiol Pharmacol 80:638–643CrossRef
6.
go back to reference Haveman J, Castro-Kreder N, Rodermond HM, van Bree C, Franken NA, Stalpers LJ, Zdzienicka MZ, Peters GJ (2004) Cellular response of X-ray sensitive hamster mutant cell lines to gemcitabine, cisplatin and 5-fluorouracil. Oncol Rep 12:187–192PubMed Haveman J, Castro-Kreder N, Rodermond HM, van Bree C, Franken NA, Stalpers LJ, Zdzienicka MZ, Peters GJ (2004) Cellular response of X-ray sensitive hamster mutant cell lines to gemcitabine, cisplatin and 5-fluorouracil. Oncol Rep 12:187–192PubMed
7.
go back to reference Kvols LK (2005) Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets. J Nucl Med 46:187S-190SPubMed Kvols LK (2005) Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets. J Nucl Med 46:187S-190SPubMed
8.
go back to reference Meng LH, Zhang JS, Ding J (2001) Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes. Biochem Pharmacol 62:733–741CrossRef Meng LH, Zhang JS, Ding J (2001) Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes. Biochem Pharmacol 62:733–741CrossRef
9.
go back to reference Pauwels B, Korst AEC, Andriessen V, Baay MFD, Pattyn GGO, Lambrechts HAJ, de Pooter CMJ, Lardon F, Vermorken JB (2005) Unraveling the mechanism of radiosensitization by gemcitabine: the role of TP53. Radiat Res 164:642–650CrossRef Pauwels B, Korst AEC, Andriessen V, Baay MFD, Pattyn GGO, Lambrechts HAJ, de Pooter CMJ, Lardon F, Vermorken JB (2005) Unraveling the mechanism of radiosensitization by gemcitabine: the role of TP53. Radiat Res 164:642–650CrossRef
10.
go back to reference Qing C, Jiang C, Zhang JS, Ding J (2001) Induction of apoptosis in human leukemia K-562 and gastric carcinoma SGC-7901 cells by salvicine, a novel anticancer compound. Anticancer Drugs 12:51–56CrossRef Qing C, Jiang C, Zhang JS, Ding J (2001) Induction of apoptosis in human leukemia K-562 and gastric carcinoma SGC-7901 cells by salvicine, a novel anticancer compound. Anticancer Drugs 12:51–56CrossRef
11.
go back to reference Sonnemann J, Gekeler V, Ahibrecht K, Brischwein K, Liu C, Bader P, Muller C, Niethammer D, Beck JF (2004) Down-regulation of protein kinase Cη by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel. Cancer Lett 209:177CrossRef Sonnemann J, Gekeler V, Ahibrecht K, Brischwein K, Liu C, Bader P, Muller C, Niethammer D, Beck JF (2004) Down-regulation of protein kinase Cη by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel. Cancer Lett 209:177CrossRef
12.
go back to reference Zhang M, Boyer M, Rivory L, Hong A, Clarke S, Stevens G, Fife K (2004) Radiosensensitization of vinorelbine and gemcitabine in NCL-H460 non-small-cell lung cancer cell. Int J Radiat Oncol Biol Phys 58:353–360CrossRef Zhang M, Boyer M, Rivory L, Hong A, Clarke S, Stevens G, Fife K (2004) Radiosensensitization of vinorelbine and gemcitabine in NCL-H460 non-small-cell lung cancer cell. Int J Radiat Oncol Biol Phys 58:353–360CrossRef
14.
go back to reference Hao DC, Xiao PG, Gu XJ (2015) Chemical and biological studies of Aconitum pharmaceutical resources. In: Hao DC, Gu XJ, Xiao PG (eds) Medicinal Plants -Chemistry, Biology and Omics-. Elsevier Amsterdam, pp 253–292 Hao DC, Xiao PG, Gu XJ (2015) Chemical and biological studies of Aconitum pharmaceutical resources. In: Hao DC, Gu XJ, Xiao PG (eds) Medicinal Plants -Chemistry, Biology and Omics-. Elsevier Amsterdam, pp 253–292
15.
go back to reference Liang XX, Gao YY, Luan SX (2018) Two decades of advances in diterpenoid alkaloids with cytotoxicity activities. RSC Adv 8:23937–23946CrossRef Liang XX, Gao YY, Luan SX (2018) Two decades of advances in diterpenoid alkaloids with cytotoxicity activities. RSC Adv 8:23937–23946CrossRef
16.
go back to reference Ren MY, Yu QT, Shi CY, Luo JB (2017) Anticancer activities of C18-, C19–, C20-, and bis-diterpenoid alkaloids derived from genus aconitum. Molecules 22:267CrossRef Ren MY, Yu QT, Shi CY, Luo JB (2017) Anticancer activities of C18-, C19–, C20-, and bis-diterpenoid alkaloids derived from genus aconitum. Molecules 22:267CrossRef
17.
go back to reference Shen Y, Liang WJ, Shi YN, Kennelly EJ, Zhao DK (2020) Structual diversity, bioactivities, and biosynthesis of natural diterpenoid alkaloids. Nat Prod Rep 37:763–796CrossRef Shen Y, Liang WJ, Shi YN, Kennelly EJ, Zhao DK (2020) Structual diversity, bioactivities, and biosynthesis of natural diterpenoid alkaloids. Nat Prod Rep 37:763–796CrossRef
18.
go back to reference Wada K, Yamashita H (2019) Cytotoxic effects of diterpenoid alkaloids against human cancer cells. Molecules 24:2317CrossRef Wada K, Yamashita H (2019) Cytotoxic effects of diterpenoid alkaloids against human cancer cells. Molecules 24:2317CrossRef
19.
go back to reference Wada K, Hazawa M, Takahashi K, Mori T, Kawahara N, Kashiwakura I (2007) Inhibitory effects of diterpenoid alkaloids on the growth of A172 human malignant cells. J Nat Prod 70:1854–1858CrossRef Wada K, Hazawa M, Takahashi K, Mori T, Kawahara N, Kashiwakura I (2007) Inhibitory effects of diterpenoid alkaloids on the growth of A172 human malignant cells. J Nat Prod 70:1854–1858CrossRef
20.
go back to reference Hazawa M, Wada K, Takahashi K, Mori T, Kawahara N, Kashiwakura I (2009) Suppressive effects of novel derivatives prepared from Aconitum alkaloids on tumor growth. Invest New Drugs 27:111–119CrossRef Hazawa M, Wada K, Takahashi K, Mori T, Kawahara N, Kashiwakura I (2009) Suppressive effects of novel derivatives prepared from Aconitum alkaloids on tumor growth. Invest New Drugs 27:111–119CrossRef
21.
go back to reference Wada K, Hazawa M, Takahashi K, Mori T, Kawahara N, Kashiwakura I (2011) Structure-activity relationships and the cytotoxic effects of novel diterpenoid alkaloid derivatives against A549 human lung carcinoma cells. J Nat Med 65:43–49CrossRef Wada K, Hazawa M, Takahashi K, Mori T, Kawahara N, Kashiwakura I (2011) Structure-activity relationships and the cytotoxic effects of novel diterpenoid alkaloid derivatives against A549 human lung carcinoma cells. J Nat Med 65:43–49CrossRef
22.
go back to reference Wada K, Ohkoshi E, Bastow KF, Morris-Natschke SL, Lee KH (2012) Cytotoxic esterified diterpenoid alkaloid derivatives with increased selectivity against a drug-resistant cancer cell line. Bioorg Med Chem Lett 22:249–252CrossRef Wada K, Ohkoshi E, Bastow KF, Morris-Natschke SL, Lee KH (2012) Cytotoxic esterified diterpenoid alkaloid derivatives with increased selectivity against a drug-resistant cancer cell line. Bioorg Med Chem Lett 22:249–252CrossRef
23.
go back to reference Wada K, Ohkoshi E, Zhao Yu, Goto M, Morris-Natschke SL, Lee KH (2015) Evaluation of Aconitum diterpenoid alkaloids as antiproliferative agents. Bioorg Med Chem Lett 25:1525–1531CrossRef Wada K, Ohkoshi E, Zhao Yu, Goto M, Morris-Natschke SL, Lee KH (2015) Evaluation of Aconitum diterpenoid alkaloids as antiproliferative agents. Bioorg Med Chem Lett 25:1525–1531CrossRef
24.
go back to reference Wada K, Goto M, Shimizu T, Kusanagi N, Li KP, Lee KH, Yamashita H (2019) Structure-activity relationships and evaluation of esterified diterpenoid alkaloid derivatives as antiproliferative agents. J Nat Med 73:789–799CrossRef Wada K, Goto M, Shimizu T, Kusanagi N, Li KP, Lee KH, Yamashita H (2019) Structure-activity relationships and evaluation of esterified diterpenoid alkaloid derivatives as antiproliferative agents. J Nat Med 73:789–799CrossRef
25.
go back to reference Calcabrini A, Meschini S, Stringaro A, Cianfriglia M, Aracia G, Molinari A (2000) Detection of P-glycoprotein in the nuclear envelope of multidrug resistant cells. Histochem J 32:599–606CrossRef Calcabrini A, Meschini S, Stringaro A, Cianfriglia M, Aracia G, Molinari A (2000) Detection of P-glycoprotein in the nuclear envelope of multidrug resistant cells. Histochem J 32:599–606CrossRef
26.
go back to reference Dennison JB, Jones DR, Renbarger JL, Hall SD (2007) Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes. J Pharmacol Exp Ther 321:553–563CrossRef Dennison JB, Jones DR, Renbarger JL, Hall SD (2007) Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes. J Pharmacol Exp Ther 321:553–563CrossRef
27.
go back to reference Bando H, Wada K, Tanaka J, Kimura S, Hasegawa E, Amiya T (1989) Two new diterpenoid alkaloids from Delphinium Pacific Giant and revised 13C-NMR assignment of delpheline. Heterocycles 29:1293–1300CrossRef Bando H, Wada K, Tanaka J, Kimura S, Hasegawa E, Amiya T (1989) Two new diterpenoid alkaloids from Delphinium Pacific Giant and revised 13C-NMR assignment of delpheline. Heterocycles 29:1293–1300CrossRef
28.
go back to reference Wada K, Yamamoto T, Bando H, Kawahara N (1992) Four diterpenoid alkaloids from Delphinium elatum. Phytochemistry 31:2135–2138CrossRef Wada K, Yamamoto T, Bando H, Kawahara N (1992) Four diterpenoid alkaloids from Delphinium elatum. Phytochemistry 31:2135–2138CrossRef
29.
go back to reference Wada K, Bando H, Amiya T (1985) Two new C20-diterpenoid alkaloids from Aconitum yesoense var. macroyesoense (NAKAI) TAMURA. Structures of dehydrolucidusculine and N-deethyldehydrolucidusculine. Heterocycles 23:2473–2477CrossRef Wada K, Bando H, Amiya T (1985) Two new C20-diterpenoid alkaloids from Aconitum yesoense var. macroyesoense (NAKAI) TAMURA. Structures of dehydrolucidusculine and N-deethyldehydrolucidusculine. Heterocycles 23:2473–2477CrossRef
30.
go back to reference Nakagawa-Goto K, Oda A, Hamel E, Ohkoshi E, Lee KH, Goto M (2015) Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring. J Med Chem 58:2378–2389CrossRef Nakagawa-Goto K, Oda A, Hamel E, Ohkoshi E, Lee KH, Goto M (2015) Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring. J Med Chem 58:2378–2389CrossRef
Metadata
Title
Bioactivity inspired C19-diterpenoid alkaloids for overcoming multidrug-resistant cancer
Authors
Koji Wada
Masuo Goto
Emika Ohkoshi
Kuo-Hsiung Lee
Hiroshi Yamashita
Publication date
25-05-2022
Publisher
Springer Nature Singapore
Published in
Journal of Natural Medicines / Issue 4/2022
Print ISSN: 1340-3443
Electronic ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-022-01629-y

Other articles of this Issue 4/2022

Journal of Natural Medicines 4/2022 Go to the issue